Avid Bioservices Inc (CDMO)

[entdoc]

KT, thought provoking. you must be a fast typist! NSCLC is a tough nut. You have to see it (in your family, or in the hospital) to believe it, and to turn advanced lung cancer around or hold it at bay is ...miraculous? I am not looking for a miracle. Nothing about the NSCLC trial results would cause me to sell. And of course any improvement at all, with Bavi's safety profile, will bode well for its extensive use in less-sick patients. If Bavi succeeds in a significant way in blocking tumor vessels, and helps the host develop immunity to tumor... it will find use on every cancer treatment table. Regardless of NSCLC outcome. What do we have for certain now? A safe, and apparently specatacular labeling agent fir diagnostic and therapeutic imaging...and also a certifiable MAB mule that one day can also deliver cytotoxin to tumor. If I had to pick between Cotara nd Bavi for lung cancer, though,I would take a slimmed-down version of PPHMs anti-TNT MAB, Cotara.